Do Normal D-dimer Levels Reliably Exclude Cerebral Sinus Thrombosis?
Stroke 35:2820-2825, Kosinski,C.M.,et al, 2004
MERCI 1, A Phase 1 Study of Mechanical Embolus Removal in Cerebral Ischemia
Stroke 35:2848-2854, Gobin,Y.P.,et al, 2004
Favorable Early Outcome of Carotid Artery Stenting Without Protection Devices
Stroke 35r:2862-2866, Sztriha,L.K.,et al, 2004
Thrombolysis for Acute Ischemic Stroke
Stroke 35:2914-2915, Wardlaw,J.,et al, 2004
Resolution of Transverse Sinus Stenosis in Idiopathic Intracranial Hypertension After L-P Shunt
Neurol 62:514-515, McGonigal,A.,et al, 2004
Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
JAMA 291:576-584, The APASS Investigators, 2004
Vertebrobasilar Dolichoectasia Diagnosed by Magnetic Resonance Angiography and Risk of Stroke and Death:A Cohort Study
JNNP 75:22-26, Ubogu,E.E.&Zaidat,O.O., 2004
Late "Spectacular Shrinking Deficit"?
Arch Neurol 61:129-130, de Assis Aquino Godim,F. &Thomas,F.P., 2004
Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004
Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004
Long-Term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
JAMA 292:1862-1866, Lindsberg,P.J.,et al, 2004
PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004
Multiple Acute Cerebral Infarcts on Diffusion-Weighted Imaging and Risk of Recurrent Stroke
Neurol 63:1317-1319, Wen,H.M.,et al, 2004
Thrombolytic Therapy in Stroke-Related Trauma
Conn Med 68:551-553, Finelli,P.F. &Beland,D., 2004
Risk Factors for Intracardiac Thrombus in Patients with Recent Ischaemic Cerebrovascular Events
JNNP 75:1421-1425, Sen,S.,et al, 2004
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
NEJM 351:2170-2178, Alexandrov,A.V.,et al, 2004
Mechanical Thrombectomy of the Internal Carotid Artery and Middle Cerebral Arteries for Acute Stroke by Using the Retriever Device
AJNR 25:1812-1815, Martinez,H.,et al, 2004
Pneumocephalus After Air Travel
Neurol 63:400-401, Jensen,M.B. &Adams,H.P., 2004
Prediction of Hospital Disposition After Thrombolysis for Acute Ischemic Stroke Using the National Institutes of Health Stroke Scale
Arch Neurol 61:1061-1064, Schlegel,D.J.,et al, 2004
Ischemic Stroke During Sexual Intercourse
Arch Neurol 61:1114-1116, Becker,K.,et al, 2004
Lacunar Infarction; Embolism is the Key: Against
Stroke 35:1779-1780, Norrving,B., 2004
Lacunar Infarction; Embolism is the Key
Stroke 35:1778-1779,1780, Futrell,N., 2004
Remote Evaluation of Acute Ischemic Stroke in Rural Community Hospitals in Georgia
Stroke 35:1763-1768, Wang,S.,et al, 2004
The Clinical-DWI Mismatch
Neurol 62:2187-2192, Davalos,A.,et al, 2004
Hyperacute Ischemic Stroke: Middle Cerebral artery Susceptibility Sign at Echo-Planar Gradient-Echo MR Imaging
Radiology 232:466-473, Rovira,A.,et al, 2004
Poststroke Neurological Improvement Within 7 Days Is Associated with Subsequent Deterioration
Stroke 35:2165, Aslanyan,S.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?"
Stroek 35:2140, Anzola,G.P.,et al, 2004
Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004
Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004
Delineation of Lateal Tentorial Sinus with Contrast-Enhanced MR Imaging and Its Surgical Implications
AJNR 25:1181-1188, Miabi,Z.,et al, 2004
Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004
Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004
Mechanism of Ischemic Infarct in Spontaneous Carotid Dissection
Stroke 35:482-485, Benninger,D.H.,et al, 2004
Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004
Tamoxifen:A New Risk Factor for Cerebral Sinus Thrombosis
Neurol 62:334-335, Masjuanh,J.,et al, 2004
Influence of Recanalization on Outcome in Dural Sinus Thrombosis, A Prospective Study
Stroke 35:544-547, Stolz,E.,et al, 2004
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:664-670, Ferro,J.M.,et al, 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Early Risk of Recurrence by Subtype of Ischemic Stroke in Population-Based Incidence Studies
Neurol 62:569-573, Lovett,J.K.,et al, 2004
The Clinical Significance of Diffusion-Weighted MR Imaging in Infratentorial Strokes
Neurol 62:574-580, Englelter,S.T.,et al, 2004
Postpartum Angiopathy with Reversible Posterior Leukoencephalopathy
Arch Neurol 61:411-416, Singhal,A.B., 2004
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004
Association of Outcome with Early Stroke Treatment:Pooled Analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials
Lancet 363:768-774, The ATLANTIS,ECASS,and NINDS rt-PA Study Group, 2004
Contrast Enhancement and Contrast Extravasation on Computed Tomography After Intra-Arterial Thrombolysis in Patients with Acute Ischemic Stroke
Stroke 35:876-881, Yoon,W.,et al, 2004